Growth funding Curio recently secured over 10 million in first-round financing to roll out its MamaLift Plus app for postpartum depression, signaling investor confidence and a scalable product roadmap that sales teams can leverage when approaching health systems and payers.

Maternal mental health expansion With a core focus on maternal mental health across the life cycle and products like MamaLift and Fertilift, Curio presents a compelling opportunity to partner with hospitals, clinics, and school districts seeking digital therapeutics integrated into behavioral health and women’s health programs.

Public sector traction Recent partnerships with Metro Nashville Public Schools to provide maternal mental health support to teachers indicate a strategy to reach large, mission-driven organizations; this can translate into scale opportunities with educational and public sector buyers.

Awards and recognition Curio’s Most Innovative Company Award from BioNJ’s BioPartnering Conference enhances credibility with potential customers and grant providers, supporting conversations with health systems and insurers about innovative, evidence-based digital therapeutics.

Evidence-based engagement Curio emphasizes proactive identification, engagement, and scalable digital interventions across puberty to menopause, offering a differentiator for purchasers seeking measurable outcomes and cost-savings in maternal and behavioral health programs.